Literature DB >> 27690701

Calcium phosphate: a substitute for aluminum adjuvants?

Jean-Daniel Masson1, Michel Thibaudon2, Laurent Bélec3, Guillemette Crépeaux4,5.   

Abstract

INTRODUCTION: Calcium phosphate was used as an adjuvant in France in diphtheria, tetanus, pertussis and poliomyelitis vaccines. It was later completely substituted by alum salts in the late 80's, but it still remains as an approved adjuvant for the World Health Organization for human vaccination. Area covered: Thus, calcium phosphate is now considered as one of the substances that could replace alum salts in vaccines. The aim of this paper is to draw a review of existing data on calcium phosphate as an adjuvant in order to bring out the strengths and weaknesses for its use on a large scale. Expert commentary: Calcium phosphate is a compound naturally present in the organism, safe and already used in human vaccination. Beyond comparisons with the other adjuvants, calcium phosphate represents a good candidate to replace or to complete alum salts as a vaccine adjuvant.

Entities:  

Keywords:  Vaccine; adjuvant; aluminum salts; calcium phosphate; immune response; safety

Mesh:

Substances:

Year:  2016        PMID: 27690701     DOI: 10.1080/14760584.2017.1244484

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  14 in total

Review 1.  Old and new adjuvants.

Authors:  Amy S McKee; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

Review 2.  [Adjuvants].

Authors:  R Brehler
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

3.  Current Prospects in Peptide-Based Subunit Nanovaccines.

Authors:  Prashamsa Koirala; Sahra Bashiri; Istvan Toth; Mariusz Skwarczynski
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Developments in Vaccine Adjuvants.

Authors:  Farrhana Ziana Firdaus; Mariusz Skwarczynski; Istvan Toth
Journal:  Methods Mol Biol       Date:  2022

5.  Replication of Small Ruminant Lentiviruses in Aluminum Hydroxide-Induced Granulomas in Sheep: a Potential New Factor for Viral Dissemination.

Authors:  Irache Echeverría; Ricardo de Miguel; Lluís Luján; Ramsés Reina; Javier Asín; Ana Rodríguez-Largo; Antonio Fernández; Marta Pérez; Damián de Andrés
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

Review 6.  Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease.

Authors:  William Walkowski; Justin Bassett; Manmeet Bhalla; Blaine A Pfeifer; Elsa N Bou Ghanem
Journal:  Vaccines (Basel)       Date:  2021-06-02

7.  Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants.

Authors:  Andreas Svensson; Tove Sandberg; Peter Siesjö; Håkan Eriksson
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

Review 8.  Nanomaterials in the Context of Type 2 Immune Responses-Fears and Potentials.

Authors:  Martin Himly; Robert Mills-Goodlet; Mark Geppert; Albert Duschl
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

Review 9.  Toward precision adjuvants: optimizing science and safety.

Authors:  Etsuro Nanishi; David J Dowling; Ofer Levy
Journal:  Curr Opin Pediatr       Date:  2020-02       Impact factor: 2.856

Review 10.  An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery.

Authors:  Kailash C Petkar; Suyash M Patil; Sandip S Chavhan; Kan Kaneko; Krutika K Sawant; Nitesh K Kunda; Imran Y Saleem
Journal:  Pharmaceutics       Date:  2021-03-27       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.